Analysis of comptothecin resistance in yeast: relevance to cancer therapy
- 1 January 1998
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 1 (3) , 176-183
- https://doi.org/10.1016/s1368-7646(98)80037-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.Journal of Clinical Oncology, 1997
- Mitotic chromosome condensation in the rDNA requires TRF4 and DNA topoisomerase I in Saccharomyces cerevisiae.Genes & Development, 1996
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1996
- Replication origins in eukaroytesCurrent Opinion in Genetics & Development, 1996
- Topoisomerase Poisons: Harnessing the Dark Side of Enzyme MechanismJournal of Biological Chemistry, 1995
- Eukaryotic DNA topoisomerases IBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.Molecular and Cellular Biology, 1994
- YeastSaccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecinCancer Chemotherapy and Pharmacology, 1994
- The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase INucleic Acids Research, 1989